25.08.2022 Ecraid intensifies efforts against monkeypox Ecraid augments its response to the expanding monkeypox outbreak in Europe proportionate to the current perceived risk.
5.08.2022 A multi-country study of monkeypox being launched – first cases enrolled in Geneva Ecraid is part of yet another promising initiative aimed at tackling the monkeypox outbreak.
7.07.2022 European response to monkeypox virus outbreak Ecraid is assessing its readiness to respond in the event the monkeypox outbreak spreads further in Europe.